|
National Stock Number(NSN): 6505-01-308-6192 (6505013086192, 013086192)
| NIIN: |
01-308-6192 |
Item Name: |
GENTAMICIN SULFATE INJECTION |
INC: |
37890
|
| FSC: |
6505
|
Assignment Date: |
Oct-01-1989 |
CRIT: |
X |
IIG: |
37890 |
| ISC: |
5 |
Date Standardized: |
Oct-01-1989 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Oct-22-2024 |
PMIC: |
U |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
3004.20.0060 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
30-818-OK-02 |
70048
|
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV |
H |
5 |
1 |
6 |
54 |
|
|
|
|
|
|
|
3401-02 |
70048
|
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV |
H |
5 |
1 |
6 |
54 |
|
|
|
|
|
|
|
ADD-VANTAGE |
70048
|
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV |
H |
5 |
1 |
6 |
54 |
|
|
|
|
|
|
|
NDC00074-3401-01 |
70048
|
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV |
H |
3 |
2 |
6 |
54 |
|
|
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
10.000 MILLIGRAMS GENTAMICIN SULFATE EQUIVALENT |
| CQCT |
PRIMARY CONTAINER TYPE |
VIAL |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
2.000 MILLILITERS |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
50 |
| CSGS |
ADMINISTRATION |
INTRAMUSCULAR |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V540 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
|